Deliver Your News to the World

CybeRelease: (OTC: SSPE) Releases ART OF WAR 2 Fight Card


(CybeRelease, April 11, 2007) - Lake Harmony, PA - SUN Sports & Entertainment Inc. (Other OTC PK: SSPE) announced that following a successful world premiere event last March 9th at Dallas’ American Airlines Center, ART OF WAR Undisputed Arena Fighting Championships are now set in Austin, Texas.

The stage is set for Mixed-Martial Arts fighting, America’s fastest growing sport, on Friday, May 11 at the Austin (Texas) Convention Center when SUN Sports & Entertainment presents...ART OF WAR 2. Ten exciting fights are scheduled for the circle cage, starting at 7:30 p.m.

In Dallas, UFC veterans Pedro Rizzo and Justin Eilers battled for the newly formed IFA World Heavyweight Championship.

Once again, it will be highly regarded heavyweight contenders in the Main Event for the May 11th, ART OF WAR 2 in Austin. Wes “The Project” Sims (21-8-1...Lancaster, Ohio), a former UFC and IFL contender and one of the world’s tallest fighters at 6’10“, will be taking on MMA veteran Chris ”The Gallatin" Guillen (33-7...St. George, Utah).

Also slated for featured action on the card is Austin MMA star and IFL contender, Freddie Espiricueta. Espiricueta will have his hands full with former UFC World title challenger, David “The Crow” Loiseau.

Other Austin fighters participating on the card include; Matt Thompson, Ryan Larson and Kamal Shalorus. Pride and UFC veteran, Alex Andrade, of Dallas, will be battling Brandon McDowell in a special attraction bout.

Tickets for ART OF WAR 2 are priced at $250 (Cageside VIP Package), $100, $60, $40 & $25. Tickets are available on line at, as well as all GetTix locations (including: Runtex locations, Waterloo Records, University Co-op in Austin and Sundance Records in San Marcus), beginning Saturday, April 14th 2007 at 10:00 a.m.

To read the complete release, go to

For a Free Newsletter, go to

CybeRelease Gainers are Amarin Corporation PLC (Nasdaq: AMRN), Alfacell Corporation (Nasdaq: ACEL), Emisphere Technologies, Inc. (Nasdaq: EMIS), Genelabs Technologies, Inc. (Nasdaq: GNLB), Mikohn Gaming Corporation (Nasdaq: PGIC), Syntroleum Corporation (Nasdaq: SYNM), Acusphere, Inc. (Nasdaq: ACUS) and Empire Resorts, Inc. (Nasdaq: NYNY).

CybeRelease Decliners are ImClone Systems Incorporated (Nasdaq: IMCL), La Jolla Pharmaceutical Company (Nasdaq: LJPC), Antigenics Inc. (Nasdaq: AGEN), Jones Soda Co. (Nasdaq: JSDA), Harris Interactive, Inc. (Nasdaq: HPOL), Comtech Group, Inc. (Nasdaq: COGO), Pharmacyclics, Inc. (Nasdaq: PCYC) and Fuel-Tech, N.V. (Nasdaq: FTEK).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.